Our research goals include:
Characterizing the role of toll like receptors in lung ischemia reperfusion injury
Developing novel therapeutic approaches for prevention of lung ischemia reperfusion injury
Identifying the regulatory pathways that drive ischemic tolerance.
Bayer Institute for Health Care Communication
International Society for Heart and Lung Transplantation XVIVO Perfusion, Inc.
National Heart, Lung, and Blood Institute
National Institutes of Health
Roche Laboratories, Inc.
US Department of Veterans Affairs
Thoracic Surgery Foundation for Research and Education
Western Thoracic Surgical Association